Clinical Trial Update: A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Colorectal Cancer

View source ↗

Summary

This clinical trial investigates whether peptidoglycan fragments derived from gut microbiota are associated with colorectal cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Zhujiang Hospital | Conditions: Colorectal Cancer | Status: RECRUITING